Please ensure Javascript is enabled for purposes of website accessibility

Calumet Specialty Products Partners: 2 Reasons to Avoid This High-Yield MLP

By Adam Galas – Feb 2, 2016 at 2:35PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

This specialty refiner has been beaten down to incredible levels, resulting in a sky-high yield. Here's why it's well earned and why you should probably stay away from this value trap.


Source: Calumet Specialty Products Partners\.

The most severe oil crash in 50 years has devastated numerous energy stocks, but most refiners have been spared the worst of the carnage because low oil prices usually boost their margins. This hasn't been the case with specialty refiner Calumet Specialty Products Partners (CLMT 1.49%), which the market has bludgeoned, pulling it down to its lowest levels since the financial crisis.

CLMT Chart
CLMT data by YCharts

This unit-price crash has resulted in a sky-high yield that may tempt many income investors. However, such a high yield also represents the market's opinion that the current payout is likely facing an imminent cut. Let's look at two reasons that I no longer have faith that Calumet represents a great long-term income opportunity and may instead be a value trap..

Valuation at multi-year lows

Yield 5-Year Average Yield Price/Operating Cash Flow9-Year Average Price/Operating Cash Flow 
16.9% 9.1%  5.7  7.6 

Sources: Yahoo! Finance, Fastgraphs.

Calumet has never exactly been a high-priced MLP. However, at today's six year lows, it's trading especially cheap. As history's greatest investor, Warren Buffett, once famously said, "It's far better to buy a wonderful company at a fair price than a fair company at a wonderful price."

So why don't I consider Calumet a wonderful company? Because of the thing that matters most to dividend investors -- the payout profile.

Payout profile doesn't inspire confidence in sustainability of distribution


Source: Calumet Specialty Products Partners investor presentation.

MLPs such as Calumet are all about income. However, successful long-term income investing requires looking at more than just yield. Payout sustainability and long-term realistic growth prospects are equally, if not more, important.

From that perspective, Calumet's payout profile leaves a lot to be desired. Specifically, it's struggled to maintain a minimal sustainable distribution coverage ratio -- the best metric for measuring long-term distribution sustainability -- of 1.0 over the past three years. In fact, only the recent margin-boosting effects of super-low oil prices have allowed it to secure the current payout.

Oil prices are certain to recover eventually, and when they do, margin compression is likely to severely hurt distributable cash flow. This makes analyst five-year distribution growth projections of 6.5% CAGR not just unlikely but, from a long-term perspective, a very bad idea.

That's because Calumet needs to emphasize growing its coverage ratio over time. Doing so would serve two vital purposes. First, it would create a cushion to decrease the risk to the current payout when cyclical refining margins decline.

As importantly, it would create a stream of excess DCF, which the MLP could use to pay down its debt and fund more growth projects and acquisitions internally, rather than rely entirely on the debt and equity markets. Which brings me to the likely reason Wall Street has crushed Calumet's unit price so badly.

Risks explain market's pessimism

Metric Calumet Specialty Products Partners 
Debt/EBITDA (leverage) ratio 12.1
Cost of debt 7.8%
Operating income/interest (interest coverage) ratio 1.14
Historic funding sources 53% debt, 47% equity
WACC 6.89%
ROIC 0.93%

Sources: GuruFocus, Morningstar.

Calumet has an incredibly leveraged balance sheet, and since it pays out almost all its DCF to investors, it's entirely reliant on external funding sources for both growth capital and refinancing its debt. Historically, the MLP has funded growth pretty evenly, which is where its main problem now lies.

With its unit price so low, it can't sell more units to fund growth, which means it must rely purely on debt markets. However, because of its already large debt burden it has a "B+" credit rating from Standard & Poor's. That junk credit rating explains Calumet's high debt cost. 

Given that the Federal Reserve continues to signal long-term interest rates are likely to go up over time, Calumet's weighted average cost of capital will probably rise over time. With its return on invested capital already very low, this makes further profitable growth difficult. That, in turn, could make growing the DCR high enough to sustain the current payout before the next refining industry downturn virtually impossible.

In the meantime, Calumet's complete reliance on its creditors means that they may pressure the MLP to slash or even eliminate the payout to use cash flow to pay down its debt.

Bottom line
Despite the recent completion of Calumet's multi-year organic growth initiative -- which may very well preserve the distribution in the short-term -- I believe that Wall Street's high-yield is warranted.

Calumet's highly leveraged balance sheet, high cost of debt, and current lack of access to equity capital markets means that future profitable growth could be limited. With its historic difficulty in maintaining a sustainable level of DCF relative to its enormous payout, income investors must understand that this is a highly speculative investment.

With so many midstream MLPs -- with far more stable business models and more sustainable distributions -- yielding 15%-plus, I think there are far better high-yield choices available in today's market.

Adam Galas has no position in any stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Calumet Specialty Products Partners Stock Quote
Calumet Specialty Products Partners
CLMT
$13.61 (1.49%) $0.20

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
339%
 
S&P 500 Returns
109%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 10/06/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.